Evidence map›Paper›PMID 20340170›Full record

ArticleSynapse (New York, N.Y.)2010

Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expression.

Neil M Richtand, Yanhong Liu, Rebecca Ahlbrand, Juliana R Sullivan, Amy Hauck Newman, Robert K McNamara

Open access · greenAbstract read
In one paragraph

Article in Synapse (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Modulation of DBiomedicines · 2024
    Article
  2. Review
  3. Review
  4. Review
  5. Abnormalities of Dopamine DJournal of central nervous system disease · 2017
    Review
  6. Immunomodulatory Effects Mediated by Dopamine.Journal of immunology research · 2016
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Neil M RichtandDepartment of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. Neil.Richtand@uc.edu
Yanhong Liu
Rebecca Ahlbrand
Juliana R Sullivan
Amy Hauck Newman
Robert K McNamara
University of Cincinnati Medical Center · USNational Institute on Drug Abuse · USVeterans Health Administration · US

Funding

Novel Dopamine D3 Receptor Ligands ZIADA000424 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 2009 to 2025
$25.9M
Role of D3 dopamine receptor in behavioral sensitizationR01DA016778 · NIDA · UNIVERSITY OF CINCINNATI · PI RICHTAND, NEIL MARK · 2004 to 2007
$1.2M
Antipsychotics, hypoglycemia, glutamate and cognitionR21MH083192 · NIMH · UNIVERSITY OF CINCINNATI · PI RICHTAND, NEIL MARK · 2008 to 2009
$386k
Intramural NIH HHSNIDA NIH HHS R01 DA016778NIMH NIH HHS R21 MH083192NIMH NIH HHS R21MH083192PHS HHS R01 16778
6 · The paper itself

Abstract

Dopamine D3 receptors have the highest dopamine affinity of all dopamine receptors, and may thereby regulate dopamine signaling mediated by volume transmission. Changes in D3 receptor isoform expression may alter D3 receptor function, however, little is known regarding coordination of D3 isoform expression in response to perturbations in dopaminergic stimulation. To determine the effects of dopamine receptor stimulation and blockade on D3 receptor alternative splicing, we determined D3 and D3nf isoform mRNA expression following treatment with the D3 receptor antagonist NGB 2904, and the indirect dopamine agonist amphetamine. Expression of tyrosine hydroxylase (TH) mRNA, the rate-limiting enzyme in dopamine synthesis, was also determined. The D3/D3nf mRNA expression ratio was increased in ventral striatum, prefrontal cortex, and hippocampus 6 h following D3 antagonist NGB 2904 treatment, and remained persistently elevated at 24 h in hippocampus and substantia nigra/ventral tegmentum. D3 mRNA decreased 65% and D3nf mRNA expression decreased 71% in prefrontal cortex 24 h following amphetamine treatment, however, these changes did not reach statistical significance. TH mRNA expression was unaffected by D3 antagonist NGB 2904, but was elevated by amphetamine in ventral striatum, hippocampus, and prefrontal cortex. These findings provide evidence for an adaptive response to altered D3 receptor stimulation involving changes in D3 receptor alternative splicing. Additionally, these data suggest D3 autoreceptor regulation of dopamine synthesis does not involve regulation of TH mRNA expression. Finally, the observation of regulated TH mRNA expression in dopamine terminal fields provides experimental support for the model of local control of mRNA expression in adaptation to synaptic activity.

Indexed as

Adaptation, PhysiologicalAlternative SplicingAnimalsDopamineDopamine AntagonistsGene Expression RegulationMaleMiceMice, Inbred C57BLMice, Inbred DBAPresynaptic TerminalsProtein IsoformsReceptors, Dopamine D3RNA, MessengerSynaptic TransmissionTime FactorsDopamineDopamine AntagonistsProtein IsoformsReceptors, Dopamine D3RNA, MessengerTyrosine 3-Monooxygenase

Identifiers

PMID20340170
PMCPMC2888922
OpenAlexW2004477634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.